Health ❯ Healthcare ❯ Medical Research

Pharmacology

GLP-1 Receptor Agonists GLP-1 Drugs Diabetes Medications Statins Obesity Treatment Antivenom Development Anti-Diabetic Medications Epilepsy Treatment GLP-1 Medications Statin Therapy Glucagon-like Peptide-1 Receptor Agonists Melatonin Supplements PARP Inhibitors Diabetes Treatment Cancer Research Oseltamivir Metformin Experimental Drugs Therapies Jet Lag Treatment Opioid Research Proton Pump Inhibitors Non-Steroidal Anti-Inflammatory Drugs Antiseizure Medications Drug Treatments Drug Treatment Hydroxyurea Diabetes GLP1-RAs SGLT Inhibitors Acetaminophen Renin-Angiotensin System Inhibitors Ovarian Function Antifibrotic Therapy Gabapentin Antidepressants Obesity Drug Development Smoking Cessation Anticoagulants Melatonin Use Geroprotectors Beta-blockers Hypertension Antibiotic Development

Mouse Study Finds Semaglutide Directly Reprograms Liver Cells to Ease Disease Without Weight Loss

The finding suggests a liver pathway that, if confirmed in people, could shift dosing and insurer criteria.

Antidepressant Fluvoxamine Eases Long COVID Fatigue in Randomized Trial

Studies Link GLP-1 Drugs to Lower Addiction and Overdose Risks

Heart Risks Rebound After GLP-1 Breaks, New Data Show Continuous Use Is Safest

Nature Papers Reveal 'Reverse' GPCR Switch That Boosts Opioid Analgesia in Preclinical Tests

Meta-Analysis Finds GLP-1 Drugs Show Little Short-Term Impact on Obesity-Linked Cancer Risk

JAMA Meta-Analyses at Kidney Week Back Routine SGLT2 Inhibitors Across Kidney Function

Long-Term Melatonin Use Linked to Higher Heart Failure and Mortality Risk in Large EHR Study

GLP-1 Drugs Linked to Lower Overall Cancer Risk in JAMA Oncology Analysis

Peer-Reviewed OU Study Maps Amylin Receptors, Offering Tools for Next‑Gen Obesity Drugs

Metformin Linked to Lower Dementia and Mortality Risks in Overweight, Obese Adults

Frequent Gabapentin Prescriptions Tied to Increased Dementia and Cognitive Impairment Risk

Statins Linked to 39% Drop in 28-Day Mortality for Sepsis Patients

GLP-1 Agonists Tied to Higher Risk of Macular Degeneration and Rare Optic Neuropathy

Cancer drug pair extends mouse lifespan by 30% as researchers plan human trials

GLP-1 Drugs Linked to Lower Cancer Risk and Mortality in New Study